GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Odonate Inc (OTCPK:ODTCD) » Definitions » EV-to-EBIT

Odonate (Odonate) EV-to-EBIT

: -0.49 (As of Today)
View and export this data going back to 2017. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Odonate's Enterprise Value is $45.36 Mil. Odonate's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 was $-91.90 Mil. Therefore, Odonate's EV-to-EBIT for today is -0.49.

The historical rank and industry rank for Odonate's EV-to-EBIT or its related term are showing as below:

ODTCD' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.53   Med: 0   Max: 0
Current: -0.49

ODTCD's EV-to-EBIT is not ranked
in the Diversified Financial Services industry.
Industry Median: 9.49 vs ODTCD: -0.49

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Odonate's Enterprise Value for the quarter that ended in Sep. 2021 was $-90.17 Mil. Odonate's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 was $-91.90 Mil. Odonate's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2021 was 101.92%.


Odonate EV-to-EBIT Historical Data

The historical data trend for Odonate's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odonate Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-EBIT
Premium Member Only - -14.48 -2.62 -7.50 -4.62

Odonate Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.70 -4.62 -0.03 -0.25 -0.24

Competitive Comparison

For the Shell Companies subindustry, Odonate's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odonate EV-to-EBIT Distribution

For the Diversified Financial Services industry and Financial Services sector, Odonate's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Odonate's EV-to-EBIT falls into.



Odonate EV-to-EBIT Calculation

Odonate's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=45.363/-91.899
=-0.49

Odonate's current Enterprise Value is $45.36 Mil.
Odonate's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-91.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odonate  (OTCPK:ODTCD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Odonate's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2021 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2021 ) =EBIT / Enterprise Value (Q: Sep. 2021 )
=-91.899/-90.1677965
=101.92 %

Odonate's Enterprise Value for the quarter that ended in Sep. 2021 was $-90.17 Mil.
Odonate's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-91.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odonate EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Odonate's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Odonate (Odonate) Business Description

Traded in Other Exchanges
N/A
Address
3 East 28th Street, 10th Floor, New York, NY, USA, 10016
Odonate Inc is a Shell company.
Executives
Ecor1 Capital, Llc 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Boxer Capital, Llc director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Kevin C Tang director, 10 percent owner, officer: Chief Executive Officer 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Aaron I. Davis director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Craig A Johnson director C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Jeff L Vacirca director 4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121
Laura L. Johnson director C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122
Michael S Hearne officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Joseph P O'connell officer: Chief Medical Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Boxer Asset Management Inc. 10 percent owner CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY, NEW PROVIDENCE C5 00000
Robert Rosen director C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Joseph Lewis 10 percent owner PO BOX N7776, LYFORD BAHAMAS
Tang Capital Management Llc 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Tang Capital Partners Lp 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
John G Lemkey officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121

Odonate (Odonate) Headlines

From GuruFocus

Odonate Announces Expected Delisting of Its Stock

By Business Wire Business Wire 01-07-2022

Weekly CEO Buys Highlight

By Joy Hu Joy Hu 12-28-2020